Nathalie Compagnone
Algemeen Directeur bij Innovative Concepts in Drug Development SAS
Profiel
Nathalie Compagnone is the founder and currently holds the position of Chief Executive & Scientific Officer at Innovative Concepts in Drug Development SAS, which she founded in 2007.
She previously worked as Head-Laboratory at The University of California, San Francisco and as Principal at Trophos SA. Dr. Compagnone holds an MBA degree from Rutgers State University of New Jersey and an undergraduate degree from Université de Franche-Comté.
Actieve functies van Nathalie Compagnone
Bedrijven | Functie | Begin |
---|---|---|
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Algemeen Directeur | 01-01-2007 |
Eerdere bekende functies van Nathalie Compagnone
Bedrijven | Functie | Einde |
---|---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Opleiding van Nathalie Compagnone
Rutgers State University of New Jersey | Masters Business Admin |
Université de Franche-Comté | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Trophos SA engages in manufacturing and development of pharmaceutical products. It offers medicines to patients with conditions such as amyotrophic lateral sclerosis, spinal muscular atrophy and cardiac ischemia reperfusion injury. The company was founded by Antoine Beret and Michel Delaage in 1991 and is headquartered in Marseille, France. | Health Technology |
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France. | Health Technology |